Multiple Sclerosis

• There are multiple sites throughout Europe in this clinical trial. Contact Advanced Medical Services (AMS). — Mannheim, Germany

• GSK Investigational Site — Brussels, Belgium
• GSK Investigational Site — Fraiture En Condroz, Belgium
• GSK Investigational Site — Hamburg, Free and Hanseatic City of Hamburg, Germany
• GSK Investigational Site — Hamburg, Free and Hanseatic City of Hamburg, Germany

• University of Washington — Seattle, Washington, United States

• VA Connecticut Healthcare System West Haven Campus, West Haven, CT — West Haven, Connecticut, United States

• Total Eye Care — Colleyville, Texas, United States

• Mälarsjukhuset — Eskilstuna, Sweden
• Karlstad hospital — Karlstad, Sweden
• Rörelse och hälsa neuro — Linköping, Sweden
• Primärvård Mjölby — Mjölby, Sweden

• Investigational Site Number 16 — Calgary, Canada
• Investigational Site Number 10 — Halifax, Canada
• Investigational Site Number 15 — London, Canada
• Investigational Site Number 12 — Montreal, Canada

• Novartis Investigative Site — Caba, Buenos Aires, Argentina
• Novartis Investigative Site — Villa Nueva, Mendoza Province, Argentina
• Novartis Investigative Site — Salta, Salta Province, Argentina
• Novartis Investigative Site — Salta, Salta Province, Argentina

Not specified

• Investigational Site Number 056001 — Brussels, Belgium
• Investigational Site Number 056002 — Overpelt, Belgium
• Investigational Site Number 056003 — Sijsele-Damme, Belgium
• Investigational Site Number 276-003 — Bad Mergentheim, Germany